{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:17:12Z","timestamp":1789805832019,"version":"4.0.1"},"reference-count":38,"publisher":"Massachusetts Medical Society","issue":"19","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"PhaseBio Pharmaceuticals, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2019,5,9]]},"DOI":"10.1056\/nejmoa1901778","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T19:00:29Z","timestamp":1552849229000},"page":"1825-1833","source":"Crossref","is-referenced-by-count":121,"title":["Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers"],"prefix":"10.1056","volume":"380","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"first","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles V.","family":"Pollack","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Jennings","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Xu","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Arnold","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret R.","family":"Umstead","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Mays","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Brigham and Women\u2019s Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Department of Emergency Medicine, Thomas Jefferson University, Philadelphia (C.V.P.); McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.); CirQuest Labs and the University of Tennessee Health Science Center, Memphis (L.K.J.); and PhaseBio Pharmaceuticals, Malvern, PA (S.X., S.E.A., B.R.U., M.C.M., J.S.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302737"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1322"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060989"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.03.025"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67660-X"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205512"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61451-8"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318235eb4d"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742c84"},{"issue":"25","key":"e_1_3_5_14_2","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Amsterdam EA","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130(25):e344-e426.25249585","journal-title":"Circulation"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq277"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr236"},{"key":"e_1_3_5_17_2","first-page":"352","article-title":"Comparative review of oral P2Y12 inhibitors.","volume":"43","author":"Koski R","year":"2018","unstructured":"Koski R, Kennedy B. Comparative review of oral P2Y12 inhibitors. P T 2018;43:352-357.29896034","journal-title":"P T"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62191-7"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3527"},{"key":"e_1_3_5_21_2","unstructured":"Plavix (clopidogrel bisulfate). Bridgewater NJ: Bristol-Myers Squibb\/Sanofi Pharmaceuticals 2017 (package insert)."},{"key":"e_1_3_5_22_2","unstructured":"Brilinta (ticagrelor). Wilmington DE: Astra Zeneca 2016 (package insert)."},{"key":"e_1_3_5_23_2","unstructured":"Effient (prasugrel). Indianapolis: Eli Lilly 2018 (package insert)."},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0806848"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.141572"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0706859"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.009"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-622928"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502000"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510991"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1409373"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13511"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2016.05.113"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22357"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002106"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.101"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv104"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1901778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:54:44Z","timestamp":1711500884000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1901778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":38,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,5,9]]}},"alternative-id":["10.1056\/NEJMoa1901778"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1901778","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]}}}